# Oral Dosage Form New Animal Drugs; Pergolide
> **Food and Drug Administration** · Final rule. · Published 2012-03-19 · Effective 2012-03-19 · 77 FR 15960
## Document
- **Document number:** 2012-6544
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 77 FR 15960
- **CFR reference:** 21 CFR 520
- **Publication date:** 2012-03-19
- **Effective date:** 2012-03-19
- **HHS docket:** Docket No. FDA-2011-N-0003
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. The NADA provides for the veterinary prescription use of pergolide mesylate tablets in horses for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease).

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2012/03/19/2012-6544/oral-dosage-form-new-animal-drugs-pergolide)
---
*AI Analytics · CC0 1.0*